The association between the comprehensive Epstein-Barr virus serological profile and endemic Burkitt lymphoma

Supplementary Data

• Supplementary Table 1 - Supplemental Table 1. Odds ratios (OR) and 95% confidence intervals (CI) for the association between anti-EBV IgG antibody and Burkitt lymphoma (BL) status, stratified by HRPII malaria antibody level.
• Supplementary Figures 1-3s - Supplemental Figure 1. From left to right, five OR's (95%CI) are presented for each of the ten anti-EBV IgG antibodies from the array with the strongest BL associations, in the following order: (1)original OR, (2)adjusted for SE36, (3)adjusted for HRPII, (4)adjusted for SE0203, and (5)adjusted for 6NANP. Supplemental Figure 2. From left to right, two OR's (95%CI) are presented for each of the ten anti-EBV IgG antibodies from the array with the strongest BL associations, in the following order: (1)original OR, (2)adjusted for the sickle cell disease variant. Supplemental Figure 3. Each bar on the x-axis represents one probe on the array (i.e., one EBV protein), grouped according to viral life cycle. The y-axis notes the number of children with a positive IgA response to that given protein. We observed IgA reactions to proteins across the viral life cycle, but these response patterns did not differ by BL status.